Concepedia

Publication | Open Access

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

DOIFull Paper Access

58

Citations

24

References

2019

Year

Shukui Qin, Stephen L. Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen,
Therapeutic Advances in Medical Oncology

Abstract

ClinicalTrials.gov: NCT01737827. https://clinicaltrials.gov/ct2/show/NCT01737827.

References

YearCitations

Page 1